Post by Shailee Singh

Research Analyst at MarkNtel Advisors

šš¢š šžš«š¢šš'š¬ šˆš•šƒ šŒššš«š¤šžš­: š€ $79.92 šŒš¢š„š„š¢šØš§ šŽš©š©šØš«š­š®š§š¢š­š² š›š² 2032 šƒšØš°š§š„šØššš š“š”šž š’ššš¦š©š„šž ššƒš…: https://lnkd.in/gaVpdtzN Projected to grow at a remarkable 9.89% CAGR (2026ā€“2032), Nigeria's In-Vitro Diagnostics market is driven by the high burden of infectious diseases and strong government health initiatives. Key growth areas include Reagents & Kits, with AI integration reshaping diagnostics. However, import dependence and weak lab infrastructure remain critical hurdles. #InVitroDiagnostics #Healthcare #Nigeria #MedicalDevices #HealthTech

Post content